Piperazine

Piperazine

SCHEMBL14742115

C1CNCCN1.O=S(=O)(O)CCO

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.38
BLM P54132 2/20 0.38
PDE4A P27815 2/20 0.38
PTGS1 P23219 1/20 0.38
SLC6A6 P31641 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 2/20 0.37
CYP3A4 P08684 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
NFKB1 P19838 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRA6 Q16445 1/20 0.37
APP P05067 1/20 0.35
ALDH1A1 P00352 2/20 0.32
POLB P06746 2/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28079882 0.90 LMNA (0.35) LMNABLMPDE4APTGS1SLC6A6
Piperidine SCHEMBL29554180 0.88 ALDH1A1 (0.41) LMNABLMPDE4APTGS1SLC6A6
Piperazine SCHEMBL28134580 0.86 LMNA (0.43) LMNABLMPDE4APTGS1SLC6A6
Morpholine SCHEMBL14742144 0.84 MEN1 (0.44) LMNABLMPDE4APTGS1SLC6A6
SCHEMBL827 0.83
SCHEMBL249947 0.83 LMNA (0.50) LMNABLMPDE4APTGS1SLC6A6
SCHEMBL1138826 0.80
SCHEMBL4306610 0.80
SCHEMBL9001614 0.80
SCHEMBL1304651 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114246872-B Technological method and composition for improving fluidity of isethionic acid piperazine Bai Xili 南京济群医药科技股份有限公司 2024-02-06 CN claimed
CN-114246841-B Composition and medicine of isethionic acid piperdine Bai Xi 南京济群医药科技股份有限公司 2024-02-02 CN claimed
CN-112375733-B Phytohemagglutinin capable of improving stem cell performance of mesenchymal stem cells and application of phytohemagglutinin in amplification culture of mesenchymal stem cells 中国人民解放军陆军军医大学第一附属医院 2022-09-02 CN claimed
CN-112300985-B Proliferation culture medium and proliferation culture method for rapidly improving proliferation efficiency of mesenchymal stem cells of mammals 中国人民解放军陆军军医大学第一附属医院 2022-07-01 CN claimed
CN-112375733-A Phytohemagglutinin capable of improving stem cell performance of mesenchymal stem cells and application of phytohemagglutinin in mesenchymal stem cell amplification culture 中国人民解放军陆军军医大学第一附属医院 2021-02-19 CN claimed
CN-112300985-A Proliferation culture medium and proliferation culture method for rapidly improving proliferation efficiency of mesenchymal stem cells of mammals 中国人民解放军陆军军医大学第一附属医院 2021-02-02 CN claimed
CN-114246872-B Technological method and composition for improving fluidity of isethionic acid piperazine Bai Xili 南京济群医药科技股份有限公司 2024-02-06 CN disclosed
CN-114246872-B Technological method and composition for improving fluidity of isethionic acid piperazine Bai Xili 南京济群医药科技股份有限公司 2024-02-06 CN disclosed
CN-114246872-B Technological method and composition for improving fluidity of isethionic acid piperazine Bai Xili 南京济群医药科技股份有限公司 2024-02-06 CN disclosed
CN-114246841-B Composition and medicine of isethionic acid piperdine Bai Xi 南京济群医药科技股份有限公司 2024-02-02 CN disclosed
CN-114246841-B Composition and medicine of isethionic acid piperdine Bai Xi 南京济群医药科技股份有限公司 2024-02-02 CN disclosed
CN-112375733-B Phytohemagglutinin capable of improving stem cell performance of mesenchymal stem cells and application of phytohemagglutinin in amplification culture of mesenchymal stem cells 中国人民解放军陆军军医大学第一附属医院 2022-09-02 CN disclosed
CN-112300985-B Proliferation culture medium and proliferation culture method for rapidly improving proliferation efficiency of mesenchymal stem cells of mammals 中国人民解放军陆军军医大学第一附属医院 2022-07-01 CN disclosed
CN-114246841-A Composition and medicine of piperazine isethionate and quinapride 南京济群医药科技股份有限公司 2022-03-29 CN disclosed
CN-114246841-A Composition and medicine of piperazine isethionate and quinapride 南京济群医药科技股份有限公司 2022-03-29 CN disclosed
CN-114246841-A Composition and medicine of piperazine isethionate and quinapride 南京济群医药科技股份有限公司 2022-03-29 CN disclosed
CN-112375733-A Phytohemagglutinin capable of improving stem cell performance of mesenchymal stem cells and application of phytohemagglutinin in mesenchymal stem cell amplification culture 中国人民解放军陆军军医大学第一附属医院 2021-02-19 CN disclosed
CN-112300985-A Proliferation culture medium and proliferation culture method for rapidly improving proliferation efficiency of mesenchymal stem cells of mammals 中国人民解放军陆军军医大学第一附属医院 2021-02-02 CN disclosed
WO-2013033046-A2 FLUORESCENT PL MARKERS FOR ISOELECTRIC FOCUSING SEPARATIONS AND FLUORESCENT LABELING VIGH GYULA (US) 2013-03-07 WO disclosed